NC
ARRY

Nexthera Capital’s Array Biopharma Inc ARRY Stock Holding History

Nexthera Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-615,437
Closed -$7.57M – 56
2017
Q3 		$7.57M Buy
+615,437
New +$5.72M 1.95% 18
2016
Q3 		– Sell
-521,000
Closed -$1.85M – 44
2016
Q2 		$1.85M Buy
+521,000
New +$1.7M 1.61% 15

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Nexthera Capital's ARRY Position: Q4 2017 in Review

Nexthera Capital sold out of Array Biopharma Inc (ARRY) in Q4 2017, closing a stake of 615,437 shares — an estimated $7.57M sold.

Nexthera Capital first reported a position in ARRY in Q2 2016 and held it in 2 quarters. The position peaked at $7.57M in Q3 2017. 191 funds tracked by Wall St. Rank hold ARRY as of Q4 2017.

  • Nexthera Capital reported no remaining Array Biopharma Inc position as of Q4 2017 after selling out during the quarter.
  • Nexthera Capital sold 615,437 Array Biopharma Inc shares in Q4 2017, an estimated $7.57M.
  • Nexthera Capital first reported a position in Array Biopharma Inc in Q2 2016 and held it in 2 quarters.
  • Nexthera Capital's Array Biopharma Inc position peaked at $7.57M in Q3 2017.
  • 191 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2017.

Based on Nexthera Capital's 13F filing for Q4 2017, filed 14 Feb 2018.